代表论著:
1. Liu Y, Xiafei Hong, Guowang Xu, David J. Kwiatkowski. Targeting PI3K/AKT/mTORC signals in human Kidney Cancer. (Oncogene,Under Review, Corresponding Author)
2. Liu Y, David J. Kwiatkowski. Combined CDKN1A/TP53 mutation in bladder cancer is a therapeutic target.(Mol Cancer Ther, 2015 Jan;14(1):174-82)
3. Liu Y, Quang P, Gayane Badalian, Esteban Braggio, Azab F, Azab AK, Maiso P, Flores LM, Quang P, Roccaro AM, Sacco A, Ngo HT, Zhang Y, Morgan B, Carrasco R, Barrett Rollins, Ghobrial IM. Novel Tumor Suppressor Function of Glucocorticoid-Induced TNF Receptor GITR in Multiple Myeloma. Plos One. 2013 Jun 13; 8 (6).
4.Wen Y*, Liu Y*, Xu Y*, Zhao Y, Hua R, Wang K, Sun M, Li Y, Yang S, Zhang XJ, Kruse R, Cichon S, Betz RC, Nothen MM, van Steensel MA, van Geel M, Steijlen PM, Hohl D, Huber M, Dunnill GS, Kennedy C, Messenger A, Munro CS, Terrinoni A, Hovnanian A, Bodemer C, de Prost Y, Paller AS, Irvine AD, Sinclair R, Green J, Shang D, Liu Q, Luo Y, Jiang L, Chen HD, Lo WH, McLean WH, He CD, Zhang X. Loss-of-function mutations of an inhibitory upstream ORF in the human hairless transcript cause Marie Unna hereditary hypotrichosis. Nat Genet. 2009 Feb; 41(2):228-33 (*Equal Contribution)
5. Liu Y*, Zhou Fei*, Zhen Yan, Daiming Fan, Alice Alexandra, Jing-Hua Yang. Targeting dsRNA for a rapid and broad antiviral prophylaxis. FASEB J. 2011, Feb 25(5):1767-74 (*Equal contribution)
6. Sacco A, Issa GC, Zhang Y, Liu Y, Maiso P, Ghobrial IM, Roccaro AM. Epigenetic modifications as key regulators of Waldenstrom's Macroglobulinemia biology. J Hematol Oncol. 2010 Oct 7;3:38
7. Sacco A, Maiso P, Azab A, Azab F, Zhang Y, Liu Y, Ngo HT, Morgan B, Quang P, Issa G, Ghobrial IM, Roccaro AM. Key Role of MicroRNAs in Waldenstrm's Macroglobulinemia Pathogenesis. Clin Lymphoma Myeloma Leuk. 2011 Feb 1;11(1):109-11.
8. Ghobrial IM, Zhang Y, Liu Y, Ngo H, Azab F, Sacco A, Azab A, Maiso P, Morgan B, Quang P, Issa G, Roccaro A. The Bone Marrow Niche in Waldenstrom's Macroglobulinemia. Clin Lymphoma Myeloma Leuk. 2011 Feb 1; 11(1):118-20
9. Sacco A, Aujay M, Morgan B, Azab AK, Maiso P, Zhang Y, Liu Y, Azab F, Ngo HT, Issa GC, Quang P, Roccaro AM, Ghobrial IM. Carfilzomib-dependent selective inhibition of the chymotrypsin-like activity of the proteasome leads to anti-tumor activity in Waldesntrom's macroglobulinemia. Clin Cancer Res. 2011 Apr 1;17(7):1753-64
10. Zhu H, Shang D, Sun M, Choi S, Liu Q, Hao J, Figuera LE, Zhang F, Choy KW, Ao Y, Liu Y, Zhang XL, Yue F, Wang MR, Jin L, Patel PI, Jing T, Zhang X. XLinked Congenital Hypertrichosis Syndrome Is Associated with Interchromosomal Insertions Mediated by a Human-Specific Palindrome near SOX3. Am J Hum Genet. 2011 Jun 10; 88(6):819-26.
11. Ghobrial IM, Zhang Y, Liu Y, Ngo H, Azab F, Sacco A, Azab A, Maiso P, Morgan B, Quang P, Issa GC, Leleu X, Roccaro AM. Targeting the bone marrow in Waldenstrom macroglobulinemia. Clin Lymphoma Myeloma Leuk. 2011 Jun;11 Epub 2011 Apr 30.
12. Azab AK, Azab F, Quang P, Maiso P, Morgan B, Sacco A, Ngo HT, Liu Y, Zhang Y, Roccaro AM, Ghobrial IM. FGFR3 is overexpressed in Waldenstrom macroglobulinemia and its inhibition by Dovitinib induces apoptosis, and overcomes stroma-induced proliferation. Clin Cancer Res. 2011 Jul 1; 17(13):4389-99.
13. Maiso P, Liu Y, Morgan B, Azab A, Ren P, Martin MB, Zhang Y, Liu Y, Sacco A,Ngo H, Azab F, Quang P, Rodig SJ, Lin CP, Roccaro A, Rommel C, Ghobrial IM. Defining the role of TORC1 and TORC2 in multiple myeloma. Blood. 2011 Dec 22;118 (26):6860-70
14. Azab F, Azab AK, Maiso P, Calimeri T, Flores LM, Liu Y, Quang P, Roccaro AM, Sacco A, Ngo HT, Zhang Y, Morgan B, Carrasco R, Ghobrial IM. Eph-B2/ephrin-B2 interaction plays a major role in the adhesion and proliferation of Waldenstrom's Macroglobulinemia. Clin Cancer Res. 2012 Jan 1; 18(1):91-104
15. LNA-mediated anti-microRNA-155 silencing in low-grade B cell lymphomas. Zhang Y, Roccaro AM, Rombaoa C, Flores L, Obad S, Fernandes SM, Sacco A, Liu Y, Ngo H, Quang P, Azab AK, Azab F, Maiso P, Reagan M, Brown JR, Thai TH, Kauppinen S, Ghobrial IM. Blood. 2012 Aug 23;120(8):1678-86